...
机译:针对性治疗局部的无孔沟,低剂量西罗血素洗脱,可生物降解的聚合物冠状动脉支架(靶标在一起):多期,开放标签,随机的非劣级试验
Yale Univ Sch Med New Haven CT 06510 USA;
Natl Univ Ireland Lambe Inst Translat Med Galway Ireland;
Chinese Acad Med Sci Fu Wai Hosp Natl Ctr Cardiovasc Dis Beijing Peoples R China;
Roskilde Univ Hosp Dept Cardiol Roskilde Denmark;
Vrije Univ Amsterdam Med Ctr Dept Cardiol Amsterdam Netherlands;
Shanghai MicroPort Med Grp Shanghai Peoples R China;
Cardialysis Rotterdam Netherlands;
Vrije Univ Amsterdam Med Ctr Dept Cardiol Amsterdam Netherlands;
Onze Lieve Vrouw Hosp Amsterdam Dept Intervent Cardiolody Amsterdam Netherlands;
Univ Hosp Bristol NHS Fdn Trust Bristol Heart Inst Bristol Avon England;
Maasstad Ziekenhuis Dept Cardiol Rotterdam Netherlands;
Tergooi Ziekenhuis Dept Cardiol Blaricum Netherlands;
Copenhagen Univ Hosp Rigshosp Dept Cardiol Copenhagen Denmark;
Imelda Ziekenhuis Ctr Heart Bonheiden Belgium;
Silesian Med Univ Dept Invas Cardiol Katowice Poland;
Hosp Clin Barcelona Inst Invest Biomed August Pi &
Sunyer IDIBAPS Cardiovasc Inst Barcelona;
Elisabeth Hosp Contilia Heart &
Vasc Ctr Essen Germany;
Univ Hosp Wales Dept Cardiol Cardiff S Glam Wales;
Univ Erlangen Nurnberg Klinikum Furth Med Klin 1 Furth Germany;
Osped Cuore Fdn CNR Reg Toscana G Monasterio UOC Cardiol Diagnost &
Interventist Massa Italy;
Onze Lieve Vrouw Hosp Cardiovasc Res Ctr Aalst Aalst Belgium;
Med Univ Graz Dept Cardiol Graz Austria;
Clin Axium Serv Cardiol Aix En Provence France;
Univ Herzzentrum Freiburg Bad Krozingen Klin Kardiol &
Angiol 2 Bad Krozingen Germany;
Amer Heart Poland Katowice Poland;
Herzzentrum Leipzig Leipzig Germany;
Klinikum Fulda Herz Thorax Zentrum Med Klin 1 Fulda Germany;
Yale Univ Sch Med New Haven CT 06510 USA;
机译:针对性治疗局部的无孔沟,低剂量西罗血素洗脱,可生物降解的聚合物冠状动脉支架(靶标在一起):多期,开放标签,随机的非劣级试验
机译:一种新型的Abluminal槽的可生物降解聚合物Siroverimus洗脱支架的安全性和功效,用于治疗De Novo冠状病变:来自靶I和目标II试验的患者水平分析的最终五年结果
机译:一种新型的Abluminal槽的可生物降解聚合物Siroverimus洗脱支架的安全性和功效,用于治疗De Novo冠状病变:来自靶I和目标II试验的患者水平分析的最终五年结果
机译:植入新一代生物可降解聚合物西罗莫司TARGET洗脱冠状动脉支架后的3个月和12个月双重抗血小板治疗的前瞻性多中心开放标签随机对照试验:TARGET DAPT试验方案
机译:TCT-605新型腔内填充生物可降解聚合物西罗莫司洗脱支架治疗De Novo冠状动脉病变的安全性和有效性:TARGET I和TARGET II试验的患者水平汇总分析的2年结果